280 related articles for article (PubMed ID: 21338058)
1. Engineered Amp C β-lactamase as a fluorescent screening tool for class C β-lactamase inhibitors.
Tsang MW; Chan PH; So PK; Ma DL; Tsang CW; Wong KY; Leung YC
Anal Chem; 2011 Mar; 83(6):1996-2004. PubMed ID: 21338058
[TBL] [Abstract][Full Text] [Related]
2. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
3. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
4. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
[TBL] [Abstract][Full Text] [Related]
5. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T
J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896
[TBL] [Abstract][Full Text] [Related]
6. Catalytically impaired fluorescent class C β-lactamase enables rapid and sensitive cephalosporin detection by stabilizing fluorescence signals: implications for biosensor design.
Tsang MW; So PK; Liu SY; Tsang CW; Chan PH; Wong KY; Leung YC
Biotechnol J; 2015 Jan; 10(1):126-35. PubMed ID: 25181520
[TBL] [Abstract][Full Text] [Related]
7. Rational design of a novel fluorescent biosensor for beta-lactam antibiotics from a class A beta-lactamase.
Chan PH; Liu HB; Chen YW; Chan KC; Tsang CW; Leung YC; Wong KY
J Am Chem Soc; 2004 Apr; 126(13):4074-5. PubMed ID: 15053574
[TBL] [Abstract][Full Text] [Related]
8. A fluorescein-labeled AmpC β-lactamase allows rapid characterization of β-lactamase inhibitors by real-time fluorescence monitoring of the β-lactamase-inhibitor interactions.
Tsang MW; Chan PH; Liu SY; Wong KY; Leung YC
Biotechnol J; 2016 Feb; 11(2):257-65. PubMed ID: 26250526
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase.
Kim JY; Jung HI; An YJ; Lee JH; Kim SJ; Jeong SH; Lee KJ; Suh PG; Lee HS; Lee SH; Cha SS
Mol Microbiol; 2006 May; 60(4):907-16. PubMed ID: 16677302
[TBL] [Abstract][Full Text] [Related]
10. Beta-ketophosphonates as beta-lactamase inhibitors: Intramolecular cooperativity between the hydrophobic subsites of a class D beta-lactamase.
Perumal SK; Adediran SA; Pratt RF
Bioorg Med Chem; 2008 Jul; 16(14):6987-94. PubMed ID: 18572409
[TBL] [Abstract][Full Text] [Related]
11. Metallic nanoparticles bioassay for Enterobacter cloacae P99 beta-lactamase activity and inhibitor screening.
Liu R; Teo W; Tan S; Feng H; Padmanabhan P; Xing B
Analyst; 2010 May; 135(5):1031-6. PubMed ID: 20419253
[TBL] [Abstract][Full Text] [Related]
12. Validation of the AmpC β-lactamase binding site and identification of inhibitors with novel scaffolds.
Chan FY; Neves MA; Sun N; Tsang MW; Leung YC; Chan TH; Abagyan R; Wong KY
J Chem Inf Model; 2012 May; 52(5):1367-75. PubMed ID: 22559726
[TBL] [Abstract][Full Text] [Related]
13. Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion.
Crichlow GV; Kuzin AP; Nukaga M; Mayama K; Sawai T; Knox JR
Biochemistry; 1999 Aug; 38(32):10256-61. PubMed ID: 10441119
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and structural consequences of the leaving group in substrates of a class C beta-lactamase.
Ahn YM; Pratt RF
Bioorg Med Chem; 2004 Mar; 12(6):1537-42. PubMed ID: 15018927
[TBL] [Abstract][Full Text] [Related]
15. Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.
Wang X; Minasov G; Shoichet BK
Proteins; 2002 Apr; 47(1):86-96. PubMed ID: 11870868
[TBL] [Abstract][Full Text] [Related]
16. Beta-lactam antibiotic resistance: a current structural perspective.
Wilke MS; Lovering AL; Strynadka NC
Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
Kumar S; Adediran SA; Nukaga M; Pratt RF
Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
[TBL] [Abstract][Full Text] [Related]
18. Different transition-state structures for the reactions of beta-lactams and analogous beta-sultams with serine beta-lactamases.
Tsang WY; Ahmed N; Hinchliffe PS; Wood JM; Harding LP; Laws AP; Page MI
J Am Chem Soc; 2005 Dec; 127(49):17556-64. PubMed ID: 16332108
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of metallo-beta-lactamase generated from beta-lactam antibiotics.
Badarau A; Llinás A; Laws AP; Damblon C; Page MI
Biochemistry; 2005 Jun; 44(24):8578-89. PubMed ID: 15952764
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of class A and class C beta-lactamases by penems: crystallographic structures of a novel 1,4-thiazepine intermediate.
Nukaga M; Abe T; Venkatesan AM; Mansour TS; Bonomo RA; Knox JR
Biochemistry; 2003 Nov; 42(45):13152-9. PubMed ID: 14609325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
